Essity AB (publ) (ESSITY-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Essity AB (publ) (ESSITY-B) has a cash flow conversion efficiency ratio of 0.048x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr4.24 Billion ≈ $456.18 Million USD) by net assets (Skr88.16 Billion ≈ $9.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ESSITY-B days of operational coverage to measure how many days the company can operate on defensive assets alone.
Essity AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Essity AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Essity AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Essity AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brambles Ltd
AU:BXB
|
0.287x |
|
FORTUM OYJ ADR 1/5/EO340
F:FOT0
|
0.043x |
|
Brookfield Infrastructure Partners L.P
TO:BIP-UN
|
0.026x |
|
Tbea Co Ltd
SHG:600089
|
0.015x |
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
0.033x |
|
WSP Global Inc
TO:WSP
|
0.045x |
|
Fortum Oyj
HE:FORTUM
|
0.006x |
|
TELEFONICA BRASIL ADR 1
F:TSPA
|
0.075x |
Annual Cash Flow Conversion Efficiency for Essity AB (publ) (2014–2025)
The table below shows the annual cash flow conversion efficiency of Essity AB (publ) from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Essity AB (publ) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr86.04 Billion ≈ $9.26 Billion |
Skr15.46 Billion ≈ $1.66 Billion |
0.180x | -5.10% |
| 2024-12-31 | Skr88.74 Billion ≈ $9.55 Billion |
Skr16.80 Billion ≈ $1.81 Billion |
0.189x | -30.30% |
| 2023-12-31 | Skr79.41 Billion ≈ $8.55 Billion |
Skr21.57 Billion ≈ $2.32 Billion |
0.272x | +61.54% |
| 2022-12-31 | Skr76.56 Billion ≈ $8.24 Billion |
Skr12.87 Billion ≈ $1.39 Billion |
0.168x | -21.46% |
| 2021-12-31 | Skr68.51 Billion ≈ $7.37 Billion |
Skr14.67 Billion ≈ $1.58 Billion |
0.214x | -23.89% |
| 2020-12-31 | Skr63.34 Billion ≈ $6.82 Billion |
Skr17.82 Billion ≈ $1.92 Billion |
0.281x | -8.70% |
| 2019-12-31 | Skr62.80 Billion ≈ $6.76 Billion |
Skr19.35 Billion ≈ $2.08 Billion |
0.308x | +28.54% |
| 2018-12-31 | Skr54.90 Billion ≈ $5.91 Billion |
Skr13.16 Billion ≈ $1.42 Billion |
0.240x | -6.65% |
| 2017-12-31 | Skr49.57 Billion ≈ $5.33 Billion |
Skr12.73 Billion ≈ $1.37 Billion |
0.257x | -20.46% |
| 2016-12-31 | Skr39.58 Billion ≈ $4.26 Billion |
Skr12.78 Billion ≈ $1.38 Billion |
0.323x | +44.57% |
| 2015-12-31 | Skr48.27 Billion ≈ $5.20 Billion |
Skr10.78 Billion ≈ $1.16 Billion |
0.223x | +2.81% |
| 2014-12-31 | Skr44.92 Billion ≈ $4.83 Billion |
Skr9.76 Billion ≈ $1.05 Billion |
0.217x | -- |
About Essity AB (publ)
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutio… Read more